Stable pharmaceutical formulations containing escitalopram and bupropion

Details for Australian Patent Application No. 2006304889 (hide)

Owner Forest Laboratories, Inc.

Inventors Mani, Narasimhan; Dedhiya, Mahendra G.; Chhettry, Anil

Agent Watermark

Pub. Number AU-A-2006304889

PCT Pub. Number WO2007/048080

Priority 60/727,055 14.10.05 US

Filing date 16 October 2006

Wipo publication date 26 April 2007

International Classifications

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/048080 Priority application(s): WO2007/048080

31 July 2008 Assignment before Grant

  Forest Laboratories, Inc. The application has been assigned to H. Lundbeck A/S

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304892-Surgical access port

2006304886-Antibodies with enhanced antibodydependent cellular cytoxicity activity, methods of their production and use